These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23448469)

  • 21. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.
    Chendil D; Das A; Dey S; Mohiuddin M; Ahmed MM
    Cancer Biol Ther; 2002; 1(2):152-60. PubMed ID: 12170775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
    Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
    Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.
    Chendil D; Ranga RS; Meigooni D; Sathishkumar S; Ahmed MM
    Oncogene; 2004 Feb; 23(8):1599-607. PubMed ID: 14985701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-kappaB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation.
    Kim BY; Kim KA; Kwon O; Kim SO; Kim MS; Kim BS; Oh WK; Kim GD; Jung M; Ahn JS
    Carcinogenesis; 2005 Aug; 26(8):1395-403. PubMed ID: 15802300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.
    Sun Y; St Clair DK; Fang F; Warren GW; Rangnekar VM; Crooks PA; St Clair WH
    Mol Cancer Ther; 2007 Sep; 6(9):2477-86. PubMed ID: 17876045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Icariin enhances radiosensitivity of colorectal cancer cells by suppressing NF-κB activity.
    Zhang Y; Wei Y; Zhu Z; Gong W; Liu X; Hou Q; Sun Y; Chai J; Zou L; Zhou T
    Cell Biochem Biophys; 2014 Jun; 69(2):303-10. PubMed ID: 24590261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3.
    Inayat MS; Chendil D; Mohiuddin M; Elford HL; Gallicchio VS; Ahmed MM
    Cancer Biol Ther; 2002; 1(5):539-45. PubMed ID: 12496485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging targets for radioprotection and radiosensitization in radiotherapy.
    Kumar S; Singh RK; Meena R
    Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-kappaB independent mechanisms.
    Baust H; Schoke A; Brey A; Gern U; Los M; Schmid RM; Röttinger EM; Seufferlein T
    Oncogene; 2003 Nov; 22(54):8786-96. PubMed ID: 14647473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells.
    Munshi A; Kurland JF; Nishikawa T; Chiao PJ; Andreeff M; Meyn RE
    Mol Cancer Ther; 2004 Aug; 3(8):985-92. PubMed ID: 15299081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of metabolism in cancer cell radioresistance and radiosensitization methods.
    Tang L; Wei F; Wu Y; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Deng H; Cao K; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
    J Exp Clin Cancer Res; 2018 Apr; 37(1):87. PubMed ID: 29688867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.
    Nguyen KH; Hachem P; Khor LY; Salem N; Hunt KK; Calkins PR; Pollack A
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):238-46. PubMed ID: 15993550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway.
    Herrmann JL; Beham AW; Sarkiss M; Chiao PJ; Rands MT; Bruckheimer EM; Brisbay S; McDonnell TJ
    Exp Cell Res; 1997 Nov; 237(1):101-9. PubMed ID: 9417872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer.
    Catz SD; Johnson JL
    Oncogene; 2001 Nov; 20(50):7342-51. PubMed ID: 11704864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
    Conti S; Vexler A; Hagoel L; Kalich-Philosoph L; Corn BW; Honig N; Shtraus N; Meir Y; Ron I; Eliaz I; Lev-Ari S
    Integr Cancer Ther; 2018 Dec; 17(4):1225-1234. PubMed ID: 30043669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting.
    Hodzic J; Dingjan I; Maas MJ; van der Meulen-Muileman IH; de Menezes RX; Heukelom S; Verheij M; Gerritsen WR; Geldof AA; van Triest B; van Beusechem VW
    Radiat Oncol; 2015 Feb; 10():55. PubMed ID: 25888875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitization of prostate cancer by soy isoflavones.
    Raffoul JJ; Sarkar FH; Hillman GG
    Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles.
    Marques A; Belchior A; Silva F; Marques F; Campello MPC; Pinheiro T; Santos P; Santos L; Matos APA; Paulo A
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.